Stepping up to meet the challenge of freezing of gait in Parkinson's disease.

Computational modeling Freezing of gait Novel paradigms Pathophysiology Phenomenology Standardized definitions and assessments Treatment

Journal

Translational neurodegeneration
ISSN: 2047-9158
Titre abrégé: Transl Neurodegener
Pays: England
ID NLM: 101591861

Informations de publication

Date de publication:
01 05 2022
Historique:
received: 09 01 2022
accepted: 31 03 2022
entrez: 30 4 2022
pubmed: 1 5 2022
medline: 4 5 2022
Statut: epublish

Résumé

There has been a growing appreciation for freezing of gait as a disabling symptom that causes a significant burden in Parkinson's disease. Previous research has highlighted some of the key components that underlie the phenomenon, but these reductionist approaches have yet to lead to a paradigm shift resulting in the development of novel treatment strategies. Addressing this issue will require greater integration of multi-modal data with complex computational modeling, but there are a number of critical aspects that need to be considered before embarking on such an approach. This paper highlights where the field needs to address current gaps and shortcomings including the standardization of definitions and measurement, phenomenology and pathophysiology, as well as considering what available data exist and how future studies should be constructed to achieve the greatest potential to better understand and treat this devastating symptom.

Identifiants

pubmed: 35490252
doi: 10.1186/s40035-022-00298-x
pii: 10.1186/s40035-022-00298-x
pmc: PMC9057060
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

23

Informations de copyright

© 2022. The Author(s).

Références

Res Synth Methods. 2010 Jul;1(3-4):169-84
pubmed: 26061464
Transl Neurodegener. 2020 Apr 15;9:12
pubmed: 32322387
Mov Disord. 2018 Jan;33(1):128-135
pubmed: 29150872
J Parkinsons Dis. 2019;9(4):821-824
pubmed: 31524181
Neuroimage Clin. 2022;33:102941
pubmed: 35091253
Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:4034-4037
pubmed: 33018884
JAMA Neurol. 2020 Mar 1;77(3):287-288
pubmed: 31841600
Mov Disord. 2008 Feb 15;23(3):395-400
pubmed: 18067193
Mov Disord. 2019 Jun;34(6):783-790
pubmed: 31046191
Neurology. 2001 Jun 26;56(12):1712-21
pubmed: 11425939
Mov Disord. 2010 Jun 15;25(8):1012-8
pubmed: 20310009
J Nucl Med. 2019 May;60(5):671-676
pubmed: 30315142
Healthc Technol Lett. 2016 Mar 21;3(1):6-11
pubmed: 27222726
Brain. 2019 Dec 1;142(12):3906-3916
pubmed: 31665229
Mov Disord. 2014 Aug;29(9):1118-24
pubmed: 24909584
JAMA. 2018 Jun 5;319(21):2190-2201
pubmed: 29872859
Neurobiol Dis. 2014 Apr;64:60-5
pubmed: 24361601
Ann Neurol. 2019 Apr;85(4):538-549
pubmed: 30720884
Neurorehabil Neural Repair. 2020 Dec;34(12):1138-1149
pubmed: 33155506
Neurology. 2011 Aug 2;77(5):483-8
pubmed: 21775741
Mov Disord. 2020 Sep;35(9):1607-1617
pubmed: 32557868
Clin Neurophysiol. 2016 Jun;127(6):2386-93
pubmed: 27178857
Mov Disord. 2022 Feb;37(2):264-267
pubmed: 34939228
J Parkinsons Dis. 2015;5(4):881-91
pubmed: 26444088
Parkinsonism Relat Disord. 2016 Jul;28:73-9
pubmed: 27138056
Parkinsonism Relat Disord. 2013 Nov;19(11):937-42
pubmed: 23831480
Brain Stimul. 2020 Sep - Oct;13(5):1320-1322
pubmed: 32634599
Int J Environ Res Public Health. 2019 Jun 23;16(12):
pubmed: 31234571
J Parkinsons Dis. 2021;11(3):1367-1380
pubmed: 33749618
IEEE J Biomed Health Inform. 2020 Apr;24(4):1215-1225
pubmed: 31217134
Mov Disord. 2020 Feb;35(2):204-214
pubmed: 31769904
NPJ Parkinsons Dis. 2018 May 18;4:15
pubmed: 29796409
Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:847-850
pubmed: 33018117
Science. 2017 Sep 1;357(6354):891-898
pubmed: 28860381
Brain. 2019 Jul 1;142(7):2037-2050
pubmed: 31505548
J Neurol. 2015;262(4):899-908
pubmed: 25636682
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
J Neurol Sci. 2014 Sep 15;344(1-2):182-5
pubmed: 25016571
J Parkinsons Dis. 2021;11(1):271-282
pubmed: 33074191
Neurosci Biobehav Rev. 2014 Jun;43:213-27
pubmed: 24769288
NPJ Parkinsons Dis. 2015 Oct 22;1:15020
pubmed: 28725687
Brain. 2020 Oct 1;143(10):3067-3076
pubmed: 33011770
PLoS One. 2020 Apr 29;15(4):e0231984
pubmed: 32348346
J Nucl Med Technol. 2019 Dec;47(4):336-340
pubmed: 31182665
J Neurol. 2019 Feb;266(2):426-430
pubmed: 30536108
PLoS One. 2013;8(1):e52602
pubmed: 23382821
Annu Int Conf IEEE Eng Med Biol Soc. 2012;2012:1198-201
pubmed: 23366112
Curr Neurol Neurosci Rep. 2019 Jun 18;19(8):49
pubmed: 31214901
Brain. 2013 Dec;136(Pt 12):3671-81
pubmed: 24142148
Sensors (Basel). 2019 Nov 24;19(23):
pubmed: 31771246
J Nucl Med. 2007 Dec;48(12):1981-6
pubmed: 18006609
Neuroscientist. 2016 Feb;22(1):72-82
pubmed: 25398230
Lancet Neurol. 2021 Jul;20(7):505-506
pubmed: 34146503
J Neurol. 2015 Jan;262(1):41-53
pubmed: 25280861
Front Neurosci. 2019 Oct 17;13:1075
pubmed: 31680815
Mov Disord. 2013 Mar;28(3):296-301
pubmed: 23239424
Mov Disord. 2003 Apr;18(4):357-63
pubmed: 12671940
Mov Disord. 2010 Jun 15;25(8):1000-4
pubmed: 20198644
MAGMA. 2017 Apr;30(2):121-125
pubmed: 27687624
Neurobiol Dis. 2018 Dec;120:107-117
pubmed: 30196050
Parkinsonism Relat Disord. 2020 Dec;81:161-164
pubmed: 33157435
Exp Neurol. 2009 Feb;215(2):334-41
pubmed: 19061889
Gait Posture. 2020 Oct;82:254-265
pubmed: 32987345
J Neural Transm (Vienna). 2001;108(1):53-61
pubmed: 11261746
J Neuroeng Rehabil. 2021 Jan 4;18(1):1
pubmed: 33397401
NPJ Parkinsons Dis. 2019 Nov 22;5:25
pubmed: 31799377
Neurology. 2012 Feb 14;78(7):454-7
pubmed: 22262741
Neurology. 1992 Feb;42(2):333-9
pubmed: 1736161
Lancet Neurol. 2011 Aug;10(8):734-44
pubmed: 21777828
Clin Neurophysiol. 2020 Sep;131(9):2171-2180
pubmed: 32683125
Mov Disord. 2013 Sep 15;28(11):1509-19
pubmed: 24132839
Sensors (Basel). 2020 May 09;20(9):
pubmed: 32397404
Neurology. 2013 Oct 29;81(18):1611-6
pubmed: 24078735
Neuron. 2015 Apr 8;86(1):38-54
pubmed: 25856485
J Clin Med. 2020 Apr 11;9(4):
pubmed: 32290366
PLoS One. 2013 Jun 21;8(6):e66718
pubmed: 23805270
J Neurol Neurosurg Psychiatry. 2018 Nov;89(11):1181-1188
pubmed: 29666208
Gait Posture. 2013 May;38(1):104-8
pubmed: 23218729
Mov Disord. 1997 May;12(3):302-5
pubmed: 9159723
Mov Disord. 2008;23 Suppl 2:S431-8
pubmed: 18668624
Ann Neurol. 2017 Jan;81(1):129-141
pubmed: 28009063
Brain. 2013 Apr;136(Pt 4):1204-15
pubmed: 23485851
Drugs Aging. 2019 Feb;36(2):103-113
pubmed: 30556112
J Parkinsons Dis. 2020;10(2):559-571
pubmed: 32039860
Exp Neurol. 2012 Oct;237(2):464-9
pubmed: 22967858
Mov Disord Clin Pract. 2020 Mar 09;7(3):325-328
pubmed: 32258233
Mov Disord. 2020 May;35(5):895-896
pubmed: 32167610
Mov Disord. 2022 Feb;37(2):253-263
pubmed: 34939221
Parkinsonism Relat Disord. 2019 Jul;64:163-168
pubmed: 30987896
J Clin Neurosci. 2010 Aug;17(8):984-7
pubmed: 20400313
Parkinsonism Relat Disord. 2020 Oct;79:73-78
pubmed: 32889503
J Neurosci. 2013 Jul 17;33(29):11986-93
pubmed: 23864685
Mov Disord Clin Pract. 2020 Jan 14;7(2):199-205
pubmed: 32071940
Prog Neurobiol. 1992;38(1):35-56
pubmed: 1736324
Parkinsonism Relat Disord. 2009 Jun;15(5):333-8
pubmed: 18930430

Auteurs

Simon Lewis (S)

ForeFront Parkinson's Disease Research Clinic, Brain and Mind Centre, School of Medical Sciences, University of Sydney, Sydney, NSW, Australia. profsimonlewis@gmail.com.

Stewart Factor (S)

Jean and Paul Amos Parkinson's Disease and Movement Disorders Program, Emory University School of Medicine, Atlanta, GA, USA.

Nir Giladi (N)

Movement Disorders Unit, Department of Neurology, Tel-Aviv Sourasky Medical Center, Sackler School of Medicine and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.

Alice Nieuwboer (A)

Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.

John Nutt (J)

Movement Disorder Section, Department of Neurology, Oregon Health & Science University, Portland, OR, USA.

Mark Hallett (M)

Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH